{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:47:40Z","timestamp":1792298860820,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.isci.2022.105068","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T02:51:40Z","timestamp":1662173500000},"page":"105068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-8525","authenticated-orcid":false,"given":"Jing","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meehyun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Drelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Paithankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Chekalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Sze","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender","family":"Rajasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te","family":"Kent Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungtaek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2022.105068_bib1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.2021.0107","article-title":"Researchers investigate what COVID-19 does to the heart","volume":"325","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2022.105068_bib2","doi-asserted-by":"crossref","first-page":"eabe4282","DOI":"10.1126\/scitranslmed.abe4282","article-title":"Lung transplantation for patients with severe COVID-19","volume":"12","author":"Ankit","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2022.105068_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2022.105068_bib4","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/acsptsci.0c00131","article-title":"Virtual and in\u00a0vitro antiviral screening revive therapeutic drugs for COVID-19","volume":"3","author":"Bocci","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.isci.2022.105068_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-infected host cells reveals therapy targets","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2022.105068_bib6","article-title":"An OpenData portal to share COVID-19 drug repurposing data in real time","author":"Brimacombe","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2022.105068_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cells10030483","article-title":"Why cells and viruses cannot survive without an ESCRT","volume":"10","author":"Calistri","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.isci.2022.105068_bib8","article-title":"Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105068_bib9","doi-asserted-by":"crossref","first-page":"e10239","DOI":"10.15252\/msb.202110239","article-title":"A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection","volume":"17","author":"Chen","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2022.105068_bib10","doi-asserted-by":"crossref","first-page":"e107776","DOI":"10.15252\/embj.2021107776","article-title":"Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis","volume":"40","author":"Chen","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2022.105068_bib11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s42255-021-00479-4","article-title":"Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication","volume":"3","author":"Chu","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.isci.2022.105068_bib12","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41467-021-21953-3","article-title":"The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA","volume":"12","author":"Cubuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105068_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2020.10.030","article-title":"Identification of required host factors for SARS-CoV-2 infection in human cells","volume":"184","author":"Daniloski","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2022.105068_bib14","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1093\/nar\/gkaa1116","article-title":"Translational control of coronaviruses","volume":"48","author":"de Breyne","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2022.105068_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","article-title":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets","volume":"595","author":"Delorey","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2022.105068_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cels.2021.05.005","article-title":"A time-resolved proteomic and prognostic map of COVID-19","volume":"12","author":"Demichev","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.isci.2022.105068_bib17","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1038\/s41467-020-20139-7","article-title":"Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection","volume":"11","author":"Desai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105068_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.25950","article-title":"A transcriptome-based drug discovery paradigm for neurodevelopmental disorders","volume":"89","author":"Dhindsa","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2022.105068_bib19","doi-asserted-by":"crossref","first-page":"108959","DOI":"10.1016\/j.celrep.2021.108959","article-title":"Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2","volume":"35","author":"Dittmar","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2022.105068_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2022.105068_bib21","doi-asserted-by":"crossref","first-page":"578599","DOI":"10.3389\/fphar.2020.578599","article-title":"Mitochondria targeted viral replication and survival strategies\u2014prospective on SARS-CoV-2","volume":"11","author":"Gatti","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2022.105068_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug-repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2022.105068_bib23","first-page":"144","article-title":"Empowering multi-cohort gene expression analysis to increase reproducibility","volume":"22","author":"Haynes","year":"2016","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.isci.2022.105068_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2022.105068_bib25","unstructured":"IMMD Drug Discovery Business[WWW document], n.d. http:\/\/www.immd.co.jp\/en\/development.html."},{"key":"10.1016\/j.isci.2022.105068_bib26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.bmcl.2013.01.055","article-title":"Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors","volume":"23","author":"Kang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.isci.2022.105068_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s12276-021-00602-1","article-title":"Innate immune sensing of coronavirus and viral evasion strategies","volume":"53","author":"Kasuga","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2022.105068_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1348-0421.12828","article-title":"Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2","volume":"64","author":"Kato","year":"2020","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.isci.2022.105068_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2022.105068_bib30","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1038\/s41598-021-91625-1","article-title":"Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19","volume":"11","author":"Le","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2022.105068_bib31","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105068_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2022.105068_bib33","doi-asserted-by":"crossref","first-page":"198074","DOI":"10.1016\/j.virusres.2020.198074","article-title":"The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway","volume":"286","author":"Li","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.isci.2022.105068_bib34","doi-asserted-by":"crossref","first-page":"eabi9007","DOI":"10.1126\/sciimmunol.abi9007","article-title":"Pharmacological activation of STING blocks SARS-CoV-2 infection","volume":"6","author":"Li","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2022.105068_bib35","doi-asserted-by":"crossref","first-page":"eaaw8412","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2022.105068_bib36","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/s41467-019-10148-6","article-title":"Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105068_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2022.105068_bib38","doi-asserted-by":"crossref","first-page":"635371","DOI":"10.3389\/fimmu.2021.635371","article-title":"Lack of effectiveness of repurposed drugs for COVID-19 treatment","volume":"12","author":"Martinez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105068_bib39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41467-021-21289-y","article-title":"Dysregulated transcriptional responses to SARS-CoV-2 in the periphery","volume":"12","author":"McClain","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2022.105068_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41421-020-00208-3","article-title":"SARS-CoV-2\u00a0N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2","volume":"6","author":"Mu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.isci.2022.105068_bib41","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.drudis.2020.08.004","article-title":"A guide for bioinformaticians: \u2019omics-based drug discovery for precision oncology","volume":"25","author":"Mun","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2022.105068_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2022.105068_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.str.2004.10.010","article-title":"Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein","volume":"13","author":"Nelson","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.isci.2022.105068_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cels.2020.10.003","article-title":"Large-scale multi-omic analysis of COVID-19 severity","volume":"12","author":"Overmyer","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.isci.2022.105068_bib45","doi-asserted-by":"crossref","first-page":"eabd5487","DOI":"10.1126\/scitranslmed.abd5487","article-title":"Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients","volume":"12","author":"Pierce Carl","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2022.105068_bib46","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.drudis.2012.07.017","article-title":"Applications of Connectivity Map in drug discovery and development","volume":"17","author":"Qu","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2022.105068_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2022.105068_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41556-021-00821-8","article-title":"BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2","volume":"24","author":"Samelson","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2022.105068_bib49","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2666-5247(21)00027-6","article-title":"Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics","volume":"2","author":"Schroeder","year":"2021","journal-title":"Lancet. Microbe"},{"key":"10.1016\/j.isci.2022.105068_bib50","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","article-title":"SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome","volume":"193","author":"Shi","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2022.105068_bib51","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s43440-020-00155-6","article-title":"Drug repurposing approach to fight COVID-19","volume":"72","author":"Singh","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.isci.2022.105068_bib52","doi-asserted-by":"crossref","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and preclinical validation of drug indications using compendia of public gene expression data","volume":"3","author":"Sirota","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2022.105068_bib53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1, 000, 000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2022.105068_bib54","doi-asserted-by":"crossref","unstructured":"The COVID-19 Gene and Drug Set Library, 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-28582\/v1.","DOI":"10.21203\/rs.3.rs-28582\/v1"},{"key":"10.1016\/j.isci.2022.105068_bib55","doi-asserted-by":"crossref","first-page":"eabh2624","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst Monique","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2022.105068_bib56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2022.105068_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2022.105068_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-422X-6-79","article-title":"Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein","volume":"6","author":"Voss","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.isci.2022.105068_bib59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.chom.2013.08.012","article-title":"Virus budding and the ESCRT pathway","volume":"14","author":"Votteler","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2022.105068_bib60","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41556-021-00710-0","article-title":"Targeting liquid\u2013liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity","volume":"23","author":"Wang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2022.105068_bib61","doi-asserted-by":"crossref","first-page":"21415","DOI":"10.1038\/s41598-020-78402-2","article-title":"SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress","volume":"10","author":"Wruck","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2022.105068_bib62","doi-asserted-by":"crossref","first-page":"108761","DOI":"10.1016\/j.celrep.2021.108761","article-title":"SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO","volume":"34","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2022.105068_bib63","doi-asserted-by":"crossref","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of type I interferon by SARS-CoV-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2022.105068_bib64","doi-asserted-by":"crossref","first-page":"bbab249","DOI":"10.1093\/bib\/bbab249","article-title":"Published anti-SARS-CoV-2 in\u00a0vitro hits share common mechanisms of action that synergize with antivirals","volume":"22","author":"Xing","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.isci.2022.105068_bib65","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad spectrum antiviral agent niclosamide and its therapeutic potential","volume":"6","author":"Xu","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2022.105068_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.121.319060","article-title":"An immuno-cardiac model for macrophage-mediated inflammation in COVID-19 hearts","volume":"129","author":"Yang","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2022.105068_bib67","doi-asserted-by":"crossref","first-page":"eabc3582","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2022.105068_bib68","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41596-020-00430-z","article-title":"OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features","volume":"16","author":"Zeng","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2022.105068_bib69","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2022.105068_bib70","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.immuni.2021.03.002","article-title":"Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses","volume":"54","author":"Zheng","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2022.105068_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004222013402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004222013402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:15:20Z","timestamp":1724739320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004222013402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2589004222013402"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2022.105068","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2022.105068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"105068"}}